Oncology Central

Small, daily dose of Viagra may reduce colorectal cancer risk

0
A team of scientists from Augusta University (GA, USA) have demonstrated that a small, daily dose of Viagra (sildenafil) significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the disease. The findings were recently published in Cancer Prevention Research.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.